Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effects Noted in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome - CENTAURUS

NCT00296387 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00296387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effects Noted in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome - CENTAURUS
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
October 31, 2007
Enrollment
1,160 (estimated)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome